Sermorelin

Sermorelin (GHRH 1–29) – Growth Hormone Research Peptide

Sermorelin is a synthetic Growth Hormone Releasing Hormone (GHRH) analogue supplied as a laboratory reagent for biochemical and endocrinological in-vitro research. The compound is referenced in studies examining GHRH receptor activation and the associated release of somatotropin from pituitary cell preparations.

This peptide is examined in in-vitro studies of cell growth signalling, metabolic pathways, and age-related endocrine responses. Each batch is HPLC-verified for ≥99% purity and formulated to support reproducible, controlled laboratory experimentation.

Key Specifications

• Name: Sermorelin (GHRH 1–29)
• Molecular Formula: C149H246N44O42S
• Molecular Weight: ≈3,357 Da
• Form: Lyophilized Powder
• Purity: ≥99% (HPLC tested)
• Storage: Store refrigerated; protect from light and moisture
• Shelf life: Sealed lyophilizate. Shelf life 24 months from manufacture.

Research Applications

• Referenced in studies examining somatotropin secretion and pituitary cell regulation.
• Used as a reagent in assays exploring GHRH receptor signalling and endocrine pathway characterisation.
• Examined alongside GHRP-2, Ipamorelin, or structurally related peptides in comparative in-vitro research models.

A batch-specific Certificate of Analysis (CoA) is available on request and accompanies every order.